Date published: 
17 June 2019
Type: 
News
Intended audience: 
General public
Image of DNA helix superimposed over a world map

This June, over 16,000 people attended this year’s BIO International Convention in Philadelphia, Pennsylvania USA. BIO is the biggest gathering of biotechnology and pharmaceutical companies, academic institutes and governments in the world. It promotes research and innovation ideas and collaboration to improve healthcare.

Professor Ian Frazer AC led the Australian delegation and hosted a roundtable discussion. He explored the role of genomics in future healthcare and highlighted opportunities to collaborate with research.

The delegation met with a wide range of BIO attendees to promote Australia’s:

  • strong medical technology and pharmaceutical sector
  • world-class researchers
  • top-quality research infrastructure

They highlighted the benefits that Australia can provide investors, including:

  • trade, investment and cultural ties to the Asia-Pacific region
  • a globally respected regulatory system
  • smooth pathways for prescription medicines and provisional approvals
  • one of the best Intellectual Property Rights protection systems in the world
  • a market that is receptive to new products

Discussions also focused on the Australian Government’s commitment to supporting lifesaving medical research through the Medical Research Future Fund. Our National Health and Medical Industry Growth Plan is cementing Australia’s place as a world leader in health and medical research and technology development.

Find out more: